Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial

Participants with a higher starting BMI lost up to 23% of body weight, the most ever recorded in a drug trial for diabetes patients

Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at qz.com →

More in Health & Medicine

Ghana: Atiku Asks Tinubu to Explain Nigeria's Health Deal With Us After Ghana's Rejection

[Vanguard] Abuja -- Former Vice President and presidential candidate of the African Democratic Congress (ADC), Atiku Abubakar, has demanded the immediate publication of Nigeria's health agreement with…

  • Former VP Atiku urges Tinubu to release full US-Nigeria health agreement details.
  • Ghana rejected US health deal due to concerns over medical records and funding obligations.
  • Agreement covers disease surveillance, data systems, and pathogen sample procedures.

Pomegranate-Linked Substance Shows Heart Benefits in New Study

A compound associated with pomegranates could have a notable impact on heart health, scientists at King's College, London, found.

  • Urolithin A, produced from pomegranates, improves heart function in heart failure patients.
  • Study shows urolithin A enhances heart relaxation, reduces scarring, prevents heart enlargement.
  • Urolithin A activates PKGIα protein, improving calcium handling and heart relaxation.

More from Wednesday 30 September →